Cystic Fibrosis Current Trends and Summit : Current Trends and Future Directions (Sep 09, 2017)

Cystic Fibrosis Current Trends and Summit : Current Trends and Future Directions is organized by ABCOMM, Inc and would be held on Sep 09, 2017 at The Westin Fort Lauderdale, Fort Lauderdale, Florida, United States of America. This CME Conference has been approved with a maximum of 5.50 AMA PRA Category 1 Credits.

Physicians and advanced practitioners involved in the management and treatment of patients with cystic fibrosis. The clinical relevance of consequential respiratory pathogens, long-term treatment study data, the role of CFTR modulators, and the impact of clinical comorbidities such as nutritional deficits and mental health issues will be discussed. Participants will collaborate on strategies to improve patient and family education, ensure smooth transitioning from pediatric to adult care, and develop techniques to help patients improve their adherence to treatment. This educational activity is designed to be highly interactive in nature and is limited to a small number of participants. This activity is supported by an educational grant from Gilead Sciences

Conference Objectives are :
As a result of attending this activity, participants will be able to:
• Describe the clinical relevance and changing epidemiology of consequential respiratory pathogens.
• Select aerosolized antibiotics by comparing safety, efficacy, and long-term study data, and monitor outcomes for necessary treatment adjustments.
• Describe the evolution of CFTR modulators and decide when they are an appropriate addition to the treatment plan based on patient specific criteria including mutation analysis.
• Assess the impact of nutrition management, mental health screening, and treatment of comorbid conditions on overall patient outcomes.
• Outline current recommendations for transfer from the pediatric to the adult care setting.
• Appreciate the number and complexity of treatments, and involve patients and/or family in treatment management decisions to improve adherence.